India, Dec. 26 -- The shares of the company engaged in the business of research, development, manufacture, and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals, and food & nutrition products are in focus after an increase in the value of its supply extension to UNICEF.

Delta Exchange banner With a market capitalization of Rs. 2,487 crore, Panacea Biotec Ltd's shares on Friday marked a day high of Rs 419.8 per share, up 17 percent from its previous day's close price of Rs 358.5 per share. The share has given a return of 79 percent over a period of five years.

Significant Order Panacea Biotec Ltd has received an amended award from the United Nations International Children's Emergency Fund (UNICEF) for the supply ...